Last reviewed · How we verify
NCT05531721
HLH Patients - a Retrospective Study
trial testing Observation in Hemophagocytic Lymphohistiocytoses in 39 participants. Completed in 30 April 2023.
24 February 2023
Quick facts
| Lead sponsor | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 39 |
| Start date | 10 November 2022 |
| Primary completion | 24 February 2023 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Observation
Conditions studied
- Hemophagocytic Lymphohistiocytoses — all drugs for Hemophagocytic Lymphohistiocytoses →
Sponsor
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Who can join
Under 18, any sex, with Hemophagocytic Lymphohistiocytoses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monocentric, observational, retrospective, no profit study aimed to analyze factors that are significantly impacting the outcome of patients diagnosed with HLH.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05531721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation
Trials testing the same drug.
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
Other recruiting trials for Hemophagocytic Lymphohistiocytoses
Currently open trials in the same condition.
- NCT06160791 — Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) · Phase 2 · recruiting
- NCT06585124 — Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas · recruiting
- NCT05236764 — Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion · NA · active not recruiting
- NCT05882175 — Prospective Validation of the OHI Index · recruiting
- NCT03117010 — Prospective Cohort for Adult Hemophagocytosis · recruiting
Other Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna trials
Trials by the same sponsor.
- NCT07372690 — Goal Attainment Scale in Transplantation · NA · recruiting
- NCT04651569 — An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer · completed
- NCT04598789 — A Multicentre, Retrospective Study to Evaluate the Outcome of HSCT Mismatch Unrelated Donors · completed
- NCT04651179 — Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma · completed
- NCT04621201 — Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05531721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
- Last refreshed: 25 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05531721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing